Acciones

Diferencia entre revisiones de «Samples in a offered tumor sort (Table ; Supplemental Table S). In»

De Inicio

(Página creada con «Normally, there is a weak association between mutations and expression adjustments, whereas a variety of genes show mutual exclusion of mutations and expressionA Downregula...»)
 
(Sin diferencias)

Revisión actual del 06:42 18 nov 2019

Normally, there is a weak association between mutations and expression adjustments, whereas a variety of genes show mutual exclusion of mutations and expressionA Downregulated Opposing UpregulatedBRCA COAD HNSC KICH KIRC KIRP LIHC LUAD LUSC PRAD THCASRRM RBM RBM QKI PTBP ACF CELF RBMXL KHDRBS RBM ZNF YBX TRAB TIAL SRSF SRSF SRSF SFB RBMYA RBMA MATR KHDRBS HNRNPR HNRNPK HNRNPH HNRNPH HNRNPDL CELF HNRNPA SRSF SRSF RBMYJ ZCH RBM RBM ESRP CPEB CPEB RBFOX RBM RBMS RBMS RBM RBM RBFOX RBFOX PABPC NOVA MBNL CPEB MBNL SRSF SRSF SRPK SFPQ PRPFB MSI IGFBP HNRNPU HNRNPC ENOX GBP PCBP ESRP WT RBM SAMDA MBNL KHDRBS CPEB CELF CELF YBX ELAVL RBM TUT SRRM SNRNP RBMX RBM PPRC NOVA HNRNPAL GEMIN HNRNPA TIA SYNCRIP PABPC SNRPA ZRSR PABPC ANKHD ELAVL UAFL SRPK RBM RBM RBMB RBM RALY PABPC HNRNPUL FMR DAZAP CELF CNOT SRPK UAF SRSF SRP RBM LINA IGFBP HNRNPF Bioactive Compound Library web Natural Product Library Technical Information HNRNPAB HNRNPAB FUS ELAVL ELAVL ZCRB SRRM SART PTBP PRPFA KHSRP IGFBP HNRNPUL HNRNPL FXR HNRNPD RBM SRSFlog FC Blog(mutated samples)BRCA COAD HNSC KICH KIRC KIRP LIHC LUAD LUSC PRAD THCACCNV Achieve CNV LossBRCA COAD HNSC KICH KIRP LIHC LUAD LUSC PRADPABPC KHDRBS FXR ESRP TRAB IGFBP MBNL CELF RBM RBM RALY SRSF HNRNPU TRAA HNRNPAB IGFBP MBNL CNOT PABPC HNRNPAL ENOX RBM SRPK SRRM FUS UAFL SRRM RBM RBFOX SRP RBM SRSF SRSF SRPK HNRNPL IGFBP SNRPA SRSF RBM RBFOX CELF HNRNPA ELAVL HNRNPAL ZCH FXR YBX RBM EWSR PCBP SFA CPEB RBM UAFCNV Gene typeRBPDriverOtherFigure . Normally, there's a weak association between mutations and expression alterations, whereas quite a few genes show mutual exclusion of mutations and expressionA Downregulated Opposing UpregulatedBRCA COAD HNSC KICH KIRC KIRP LIHC LUAD LUSC PRAD THCASRRM RBM RBM QKI PTBP ACF CELF RBMXL KHDRBS RBM ZNF YBX TRAB TIAL SRSF SRSF SRSF SFB RBMYA RBMA MATR KHDRBS HNRNPR HNRNPK HNRNPH HNRNPH HNRNPDL CELF HNRNPA SRSF SRSF RBMYJ ZCH RBM RBM ESRP CPEB CPEB RBFOX RBM RBMS RBMS RBM RBM RBFOX RBFOX PABPC NOVA MBNL CPEB MBNL SRSF SRSF SRPK SFPQ PRPFB MSI IGFBP HNRNPU HNRNPC ENOX GBP PCBP ESRP WT RBM SAMDA MBNL KHDRBS CPEB CELF CELF YBX ELAVL RBM TUT SRRM SNRNP RBMX RBM PPRC NOVA HNRNPAL GEMIN HNRNPA TIA SYNCRIP PABPC SNRPA ZRSR PABPC ANKHD ELAVL UAFL SRPK RBM RBM RBMB RBM RALY PABPC HNRNPUL FMR DAZAP CELF CNOT SRPK UAF SRSF SRP RBM LINA IGFBP HNRNPF HNRNPAB HNRNPAB FUS ELAVL ELAVL ZCRB SRRM SART PTBP PRPFA KHSRP IGFBP HNRNPUL HNRNPL FXR HNRNPD RBM SRSFlog FC Weblog(mutated samples)BRCA COAD HNSC KICH KIRC KIRP LIHC LUAD LUSC PRAD THCACCNV Acquire CNV LossBRCA COAD HNSC KICH KIRP LIHC LUAD LUSC PRADPABPC KHDRBS FXR ESRP TRAB IGFBP MBNL CELF RBM RBM RALY SRSF HNRNPU TRAA HNRNPAB IGFBP MBNL CNOT PABPC HNRNPAL ENOX RBM SRPK SRRM FUS UAFL SRRM RBM RBFOX SRP RBM SRSF SRSF SRPK HNRNPL IGFBP SNRPA SRSF RBM RBFOX CELF HNRNPA ELAVL HNRNPAL ZCH FXR YBX RBM EWSR PCBP SFA CPEB RBM UAFCNV Gene typeRBPDriverOtherFigure . Cancer alterations in splicing things. (A) Up (red) and downregulation (blue) patterns splicing variables (xaxis) inside the distinctive tumor types (yaxis) when compared with regular samples. Only theSFs (out oftested) with differential expression are shown. The colour intensity indicates the logfold modify (log FC). The bar plot above indicates the frequency of tumor types with up (red) or down (blue) regulation for each issue. Elements are clustered into three groups as outlined by whether or not they show frequent downregulation (Downregulated) or upregulation (Upregulated) in tumors, or regardless of whether they tend to show an opposite pattern between the 3 kidney tumors (KICH, KIRC, KIRP) as well as the rest of the tumor varieties (Opposing). Components previously described to have oncogenic or tumorsuppressing activities (Supplemental Table S) are labeled in red. SFB, SRPK, SRPK, and SRPK had been incorporated for comparison. (B) Quantity of samples in log scale (yaxis) in which RBPs (green), driver genes (red) (Supplemental Tables S, S), along with the rest from the genes (blue) show mutations in each tumor type (xaxis). Distributions are represented as box plots, with outliers represented as dots. All comparisons of drivers vs. RBPs or drivers vs. other folks are significant (onesided Wilcoxon test Pvalues.). Comparisons of others vs. RBPs are considerable (onesided Wilcoxon test Pvalues.), except for LUAD, LUSC, and PRAD. Drivers were extracted in the literature (Approaches). FDA-Approved Drug Library Formula Upregulated RBPs had gen.